Treatment of Neuromyelitis Optica Spectrum Disorder: Acute, Preventive, and Symptomatic
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Treatment of Neuromyelitis Optica Spectrum Disorder: Acute, Preventive, and Symptomatic
Authors
Keywords
Neuromyelitis optica spectrum disorder, Immunosuppression, Azathioprine, Mycophenolate, Rituximab, Eculizumab
Journal
Current Treatment Options in Neurology
Volume 18, Issue 1, Pages -
Publisher
Springer Nature
Online
2015-12-26
DOI
10.1007/s11940-015-0387-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Hypoxemia, Sleep Disturbances, and Depression Correlated with Fatigue in Neuromyelitis Optica Spectrum Disorder
- (2015) Jing Pan et al. CNS Neuroscience & Therapeutics
- Azathioprine plus corticosteroid treatment in Chinese patients with neuromyelitis optica
- (2015) Wei Qiu et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Depressive state and chronic fatigue in multiple sclerosis and neuromyelitis optica
- (2015) Tetsuya Akaishi et al. JOURNAL OF NEUROIMMUNOLOGY
- Epidemiological, clinical, and immunological characteristics of neuromyelitis optica: A review
- (2015) Wildéa Lice de Carvalho Jennings Pereira et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Oral versus intravenous high-dose methylprednisolone for treatment of relapses in patients with multiple sclerosis (COPOUSEP): a randomised, controlled, double-blind, non-inferiority trial
- (2015) Emmanuelle Le Page et al. LANCET
- Protocol for a multicentre randomiSed controlled TRial of IntraVEnous immunoglobulin versus standard therapy for the treatment of transverse myelitis in adults and children (STRIVE)
- (2015) M. Absoud et al. BMJ Open
- Long-term Therapy With Interleukin 6 Receptor Blockade in Highly Active Neuromyelitis Optica Spectrum Disorder
- (2015) Marius Ringelstein et al. JAMA Neurology
- Treatment of neuromyelitis optica/neuromyelitis optica spectrum disorders with methotrexate
- (2014) Ramnath Santosh Ramanathan et al. BMC Neurology
- Evidence for classic complement activity in neuromyelitis optica
- (2014) Melina V. Jones et al. CLINICAL NEUROPATHOLOGY
- Single Dose of Glycoengineered Anti-CD19 Antibody (MEDI551) Disrupts Experimental Autoimmune Encephalomyelitis by Inhibiting Pathogenic Adaptive Immune Responses in the Bone Marrow and Spinal Cord while Preserving Peripheral Regulatory Mechanisms
- (2014) Ding Chen et al. JOURNAL OF IMMUNOLOGY
- Complement activation in patients with neuromyelitis optica
- (2014) Petra Nytrova et al. JOURNAL OF NEUROIMMUNOLOGY
- Systemic lupus erythematosus-associated acute transverse myelitis: manifestations, treatments, outcomes, and prognostic factors in 20 patients
- (2014) J Saison et al. LUPUS
- Neuropathic pain in neuromyelitis optica affects activities of daily living and quality of life
- (2014) Sizheng Zhao et al. Multiple Sclerosis Journal
- Long-term efficacy, tolerability and retention rate of azathioprine in 103 aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder patients: a multicentre retrospective observational study from the UK
- (2014) Liene Elsone et al. Multiple Sclerosis Journal
- Efficacy of the anti-IL-6 receptor antibody tocilizumab in neuromyelitis optica: A pilot study
- (2014) M. Araki et al. NEUROLOGY
- Urinary incontinence in women
- (2014) L. N. Wood et al. BMJ-British Medical Journal
- Mycophenolate Mofetil in the Treatment of Neuromyelitis Optica Spectrum Disorder
- (2014) So-Young Huh et al. JAMA Neurology
- Comparison of Relapse and Treatment Failure Rates Among Patients With Neuromyelitis Optica
- (2014) Maureen A. Mealy et al. JAMA Neurology
- Cognitive performance of neuromyelitis optica patients: comparison with multiple sclerosis
- (2013) Sandra Vanotti et al. ARQUIVOS DE NEURO-PSIQUIATRIA
- An update on prevention and treatment of catheter-associated urinary tract infections
- (2013) Peter Tenke et al. CURRENT OPINION IN INFECTIOUS DISEASES
- Efficacy of Intravenous Cyclophosphamide Therapy for Neuromyelitis Optica Spectrum Disorder
- (2013) Hiroaki Yaguchi et al. INTERNAL MEDICINE
- Methotrexate is an alternative to azathioprine in neuromyelitis optica spectrum disorders with aquaporin-4 antibodies
- (2013) J. Kitley et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Eculizumab in AQP4-IgG-positive relapsing neuromyelitis optica spectrum disorders: an open-label pilot study
- (2013) Sean J Pittock et al. LANCET NEUROLOGY
- Role of intravenous immunoglobulin in the treatment of acute relapses of neuromyelitis optica: experience in 10 patients
- (2013) Liene Elsone et al. Multiple Sclerosis Journal
- Characteristic Cerebrospinal Fluid Cytokine/Chemokine Profiles in Neuromyelitis Optica, Relapsing Remitting or Primary Progressive Multiple Sclerosis
- (2013) Takuya Matsushita et al. PLoS One
- Efficacy of Modafinil on Fatigue and Excessive Daytime Sleepiness Associated with Neurological Disorders: A Systematic Review and Meta-Analysis
- (2013) Ping Sheng et al. PLoS One
- Association of Neuromyelitis Optica With Severe and Intractable Pain
- (2012) Peiqing Qian et al. ARCHIVES OF NEUROLOGY
- Epidemiology of Neuromyelitis Optica in the United States
- (2012) Maureen A. Mealy et al. ARCHIVES OF NEUROLOGY
- Drug-Specific Th2 Cells and IgE Antibodies in a Patient with Anaphylaxis to Rituximab
- (2012) Alessandra Vultaggio et al. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY
- Efficacy of mitoxantrone in neuromyelitis optica spectrum: clinical and neuroradiological study
- (2012) P. Cabre et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Serologic diagnosis of NMO: A multicenter comparison of aquaporin-4-IgG assays
- (2012) P. J. Waters et al. NEUROLOGY
- Treatment of neuromyelitis optica: Review and recommendations
- (2012) Dorlan J. Kimbrough et al. Multiple Sclerosis and Related Disorders
- Azathioprine: Tolerability, efficacy, and predictors of benefit in neuromyelitis optica
- (2011) C. Costanzi et al. NEUROLOGY
- Interleukin 6 signaling promotes anti-aquaporin 4 autoantibody production from plasmablasts in neuromyelitis optica
- (2011) Norio Chihara et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Safety and clinical outcomes of rituximab therapy in patients with different autoimmune diseases: experience from a national registry (GRAID)
- (2011) Hans-Peter Tony et al. ARTHRITIS RESEARCH & THERAPY
- Azathioprine versus mycophenolate mofetil for long-term immunosuppression in lupus nephritis: results from the MAINTAIN Nephritis Trial
- (2010) F. A. Houssiau et al. ANNALS OF THE RHEUMATIC DISEASES
- Rehabilitation in Practice: Neurogenic lower urinary tract dysfunction and its management
- (2010) Jalesh N Panicker et al. CLINICAL REHABILITATION
- Evaluation of health-related quality of life, fatigue and depression in neuromyelitis optica
- (2010) J.-B. Chanson et al. EUROPEAN JOURNAL OF NEUROLOGY
- Does rituximab increase the incidence of infectious complications? A narrative review
- (2010) Theodoros Kelesidis et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Treatment of Neuromyelitis Optica With Mycophenolate Mofetil
- (2009) Anu Jacob et al. ARCHIVES OF NEUROLOGY
- Plasma exchange in severe spinal attacks associated with neuromyelitis optica spectrum disorder
- (2009) M Bonnan et al. Multiple Sclerosis Journal
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now